PLAU and nephrotic syndrome: We have demonstrated that the lack of urokinase plasminogen activator (Plau), plasmin (Plg), or plasma kallikrein (Klkb1) — all of which are aprotinin-sensitive — did not protect from sodium retention in experimental nephrotic syndrome of mice with genetic deletion of these proteins [4, 19, 40].